Med chem vii

24
Receptor and signal transduction

Transcript of Med chem vii

Page 1: Med chem vii

Receptor and signal transduction

Page 2: Med chem vii

Kinase and GPCR Transduction

30 % Marketed Drug

Page 3: Med chem vii

Interaction of the receptor ligand complex with G-proteins

Page 4: Med chem vii

Interaction of the receptor ligand complex with G-proteins

Page 5: Med chem vii

Signal transduction pathways involving the a α-subunit

Activation of adenylate cyclase by the α-subunit

Adenylate cyclase (or adenylyl cyclase) switch on

Page 6: Med chem vii

Signal transduction pathways involving the a α-subunit

Signaling pathways arising from the splitting of different G-proteins.

Page 7: Med chem vii

Signal transduction involving G-proteins and adenylate cyclase

Activation of adenylate cyclase by the α-subunit

Page 8: Med chem vii
Page 9: Med chem vii

Activation of protein kinase A

Page 10: Med chem vii

Regulation of glycogen synthesis and metabolism in a liver cell

Page 11: Med chem vii

Signal transduction pathways for G-protein-coupled receptors

Page 12: Med chem vii

The Gi - protein

Adenylate cyclase can also be inhibited by a different G-protein the Gi-protein. The Gi-protein interacts with

different receptors from those that interact with the Gs-Proteins but the mechanism leading to inhibition is the same as that leading to activation

The only difference is that the α-subunit released binds to adenylate cyclase and inhibits the enzyme rather than activates it.

Receptors that bind Gi-proteins include the muscarinic M2 receptor of cardiac muscle, α2-adrenoceptorsin smooth muscle, and opioid receptors in the central nervous system.

Noradrenaline interacts with the b-adrenoceptor to activate a which activates a Gs-protein, whereas acetylcholine interacts with the muscarinic receptor to activate a Gi -protein.

Page 13: Med chem vii

Phosphorylation

Page 14: Med chem vii

General points about the signaling cascade involving cyclic AMP

Firstly, the action of the G-protein and the generation of a secondary messenger explains how a message delivered to

the outside of the cell surface can be transmitted to enzymes within the cell enzymes that have no direct association with the cell membrane or the receptor. Such a signaling process avoids the difficulties involved in a messenger molecule (which iscommonly hydrophilic) having to cross a hydrophobic cell membrane.

Secondly, the process involves a molecular relay runner (the G-protein) and several different enzymes in the signaling

cascade. At each of these stages, the action of one protein or enzyme results in the activaion of a much larger number of enzymes. Therefore, the effect of one neurotransmitter interacting with one receptor molecule results in a final effect several factors larger than one might expect. For example, each molecule of adrenaline is thought to generate100 molecules of cAMP and each cAMP molecule starts off an amplification effect of its own within the cell.

Thirdly, there is an advantage in having the receptor, the G-protein, and adenylate cyclase as separate entities

Page 15: Med chem vii

Summary

G-proteins consist of three protein subunits, with the a-subunit bound to GDP. There are several types of G-protein.

Receptor–ligand binding opens a binding site for the G protein. On binding, GDP is exchanged for GTP, and the G-protein fragments into an a-subunit (bearing GTP) and a ßγ-dimer.

G-proteins are bound and split for as long as the chemical messenger is bound to the receptor, resulting in a signalamplification

An a-subunit binds to adenylate cyclase and activates it such that it catalyses the formation of cAMP from ATP. The reaction proceeds for as long as the a-subunit is bound, representing another signal amplification. An a-subunit inhibits adenylate cyclase

Page 16: Med chem vii

Tyrosine kinases are enzymes which phosphorylate the phenol group of tyrosine residues in enzyme substrates. Serine threonine kinases phosphorylate the alcohol groups of serine and threonine in enzyme substrates. In both cases, phosphorylation results in conformational changes that affect the activity of the substrate enzyme.

Kinases are involved in the desensitization of receptors.

The a-subunits eventually hydrolyse bound GTP to GDP and depart adenylate cyclase. They combine with their respective ßγ-dimers to reform the original G-proteins.

cAMP acts as a secondary messenger within the cell and activates PKA. PKA catalyses the phosphorylation of serineand threonine residues in other enzymes leading to a biological effect determined by the type of cell involved.

Page 17: Med chem vii

Signal transduction involving G-proteins and phospholipase C

G-protein effect on phospholipase C

TM receptors bind a different G-protein called a Gq-protein , which initiates a different signaling pathway. This pathway involves the activation or deactivation of a membrane-bound enzyme called phospholipase C.

Page 18: Med chem vii

Action of the secondary messenger: diacylglycerol

Diacylglycerol is a hydrophobic molecule and remains inthe cell membrane once it is formed . There, itactivates an enzyme called protein kinase C (PKC) which moves from the cytoplasm to the cell membrane and then catalyzes the phosphorylation of serine and threonine residues of enzymes within the cell.

Once phosphorylated, these enzymes are activated and catalyze specific c reactions within the cell. Th ese induce effects such as tumor propagation, inflammatory responses, contraction or relaxation of smooth muscle, the increase or decrease of neurotransmitter release, the increase or decrease of neuronal excitability, and receptor desensitization's.

Page 19: Med chem vii

Action of the secondary messenger: inositol triphosphate

Page 20: Med chem vii

Key points

Page 21: Med chem vii

Signal transduction involving kinase-linked receptors

Activation of signaling proteins and enzymes

Page 22: Med chem vii

Signal transduction involving kinase-linked receptors

Page 23: Med chem vii

Signal transduction involving kinase-linked receptors

Page 24: Med chem vii